How to Monitor Manic Switch During Ketamine Maintenance in Bipolar Depression
How should clinicians monitor for hypomania or mania during continuation or maintenance ketamine or esketamine treatment for bipolar depression?
The main safety concern in this cohort was not early switching during the acute series, but delayed hypomanic or manic symptoms during longer-term treatment. This guide applies to clinicians following patients with bipolar depression after acute ketamine or esketamine response, when maintenance treatment is being continued or tapered.
-
Distinguish acute-phase from maintenance-phase risk
Recognize that no mania or hypomania was observed during the initial acute series in this cohort, when treatments were given twice weekly. The observed safety signal emerged later during continuation or maintenance treatment, so surveillance should continue well beyond induction.
-
Continue monitoring over months, not just days or weeks
Maintain longitudinal monitoring during ongoing treatment because the mean time from first ketamine or esketamine treatment to the initial hypomanic or manic event was 297 days, with a median of 266 days and a range of 51 to 995 days. In this sample, 13 of 45 patients experienced symptoms consistent with a hypomanic or manic episode during follow-up.
-
Ask specifically about emerging activation symptoms
At follow-up visits, ask about symptoms that were used in the chart review strategy and case descriptions, including racing thoughts, irritability, grandiosity, pressured speech, agitation, increased energy, increased goal-directed activity, decreased need for sleep, and disorganization or paranoia when severe. These symptoms were central to how manic or hypomanic events were identified in the report.
-
Classify severity by intervention needed
Use the article's operational definitions to frame clinical severity. Mild hypomania was defined as an event that did not require intervention, moderate hypomania as requiring a medication change, and severe mania as requiring hospitalization or emergency department presentation.
-
Do not rely on mood stabilizers alone to rule out risk
Continue monitoring even when the patient is taking lithium, an antipsychotic, or another mood stabilizer. In this cohort, 14 of 16 manic or hypomanic events occurred while the patient was on a mood stabilizer, antipsychotic, or lithium.
-
Adjust management according to event severity
If symptoms are mild, recognize that some episodes in this cohort resolved without intervention. If symptoms are moderate, medication adjustment was the typical response, most often by using an atypical antipsychotic. If severe mania emerges, stop ketamine treatment and escalate care; in the reported severe case, the patient was hospitalized and switched from IV ketamine to electroconvulsive therapy.
-
Reassess risk when restarting or modifying maintenance treatment
Be alert when patients resume treatment after an interruption or begin a repeat acute series, because both detailed first-switch cases in the report occurred during resumed esketamine treatment after a break. In those examples, symptoms emerged during the second acute series while patients were on every-2-week maintenance schedules beforehand.
Clinical Considerations
- Manic and hypomanic events were identified retrospectively by manual electronic medical record review, so some episodes may have been missed if they did not come to medical attention.
- The study could not determine whether the observed switching rate was higher than the background cycling risk of bipolar disorder.
- Because ancillary treatments and treatment schedules were not tightly controlled, manic or hypomanic symptoms may have been related in part to other treatment changes.
- These safety observations come from a small cohort with limited racial and ethnic diversity.
Bottom Line
For bipolar depression treated with ketamine or esketamine, the key safety task is sustained maintenance-phase surveillance for delayed hypomanic or manic symptoms, because no switches were seen during acute induction but events emerged months later.
